440 filings
Page 14 of 22
424B4
ihc4i
15 Jun 18
Prospectus supplement with pricing info
12:26pm
EFFECT
0s0w0po2yo8pwt1udcs9
14 Jun 18
Notice of effectiveness
12:00am
8-K
8xbsfh
14 Jun 18
ContraVir Pharmaceuticals Announces the Approval of the IND and Initiation of the Clinical Development Program of CRV431 in the United States
12:00am
CORRESP
t8w3sfprfvt pn5bhzz
13 Jun 18
Correspondence with SEC
12:00am
8-K
kvov bm5hifdd5
13 Jun 18
ContraVir Pharmaceuticals Reminds Investors of Today’s Deadline to be a Shareholder of Record
12:00am
8-K
ml0xs
6 Jun 18
ContraVir Pharmaceuticals Informs Stockholders of Key Dates and Terms Related to Announced Rights Offering
6:01am
FWP
2u3ff1j
5 Jun 18
Free writing prospectus
4:31pm
8-K
5ju0w5
31 May 18
Other Events
8:21am
8-K
v7ngaua
30 May 18
Other Events
10:20am
CORRESP
uo8jr fzm
30 May 18
Correspondence with SEC
12:00am
8-K
5b4dmhjsq
29 May 18
ContraVir Pharmaceuticals to Present at 2018 BIO International Convention
4:29pm
UPLOAD
f2dj8sjbatj
29 May 18
Letter from SEC
12:00am
8-K
6thkvqzk9e
24 May 18
ContraVir Pharmaceuticals, Inc. Announces Reverse Stock Split
4:15pm
8-K
tqsmd6wfskyt
13 Apr 18
Other Events
12:00am
10-KT
mv1zx
26 Mar 18
Annual report (with FYE transition)
12:00am